ATE133331T1 - Vorrichtung zur kontrollierten wirkstoffreigabe - Google Patents

Vorrichtung zur kontrollierten wirkstoffreigabe

Info

Publication number
ATE133331T1
ATE133331T1 AT92203447T AT92203447T ATE133331T1 AT E133331 T1 ATE133331 T1 AT E133331T1 AT 92203447 T AT92203447 T AT 92203447T AT 92203447 T AT92203447 T AT 92203447T AT E133331 T1 ATE133331 T1 AT E133331T1
Authority
AT
Austria
Prior art keywords
active substance
core
aperture
exposed
release
Prior art date
Application number
AT92203447T
Other languages
English (en)
Inventor
Sham Kumar Chopra
North Road
Avinash Kumar Nangia
David Lee
Thomas Patrick Molloy
Original Assignee
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919124106A external-priority patent/GB9124106D0/en
Priority claimed from GB919124108A external-priority patent/GB9124108D0/en
Priority claimed from GB929205463A external-priority patent/GB9205463D0/en
Application filed by Glaxo Canada filed Critical Glaxo Canada
Application granted granted Critical
Publication of ATE133331T1 publication Critical patent/ATE133331T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT92203447T 1991-11-13 1992-11-10 Vorrichtung zur kontrollierten wirkstoffreigabe ATE133331T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919124106A GB9124106D0 (en) 1991-11-13 1991-11-13 Device
GB919124108A GB9124108D0 (en) 1991-11-13 1991-11-13 Device
GB929205463A GB9205463D0 (en) 1992-03-12 1992-03-12 Device

Publications (1)

Publication Number Publication Date
ATE133331T1 true ATE133331T1 (de) 1996-02-15

Family

ID=27265924

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92203447T ATE133331T1 (de) 1991-11-13 1992-11-10 Vorrichtung zur kontrollierten wirkstoffreigabe

Country Status (15)

Country Link
US (1) US5342627A (de)
EP (1) EP0542364B1 (de)
JP (2) JP3768247B2 (de)
AT (1) ATE133331T1 (de)
AU (1) AU658942B2 (de)
CA (1) CA2082740C (de)
CZ (1) CZ337392A3 (de)
DE (1) DE69207863T2 (de)
DK (1) DK0542364T3 (de)
ES (1) ES2083074T3 (de)
GR (1) GR3019431T3 (de)
IL (1) IL103723A0 (de)
NO (1) NO924372L (de)
NZ (1) NZ245100A (de)
TW (1) TW262387B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5398850A (en) 1993-08-06 1995-03-21 River Medical, Inc. Gas delivery apparatus for infusion
DE4341442C2 (de) * 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US5700245A (en) 1995-07-13 1997-12-23 Winfield Medical Apparatus for the generation of gas pressure for controlled fluid delivery
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
EP1095650A1 (de) * 1999-10-29 2001-05-02 Universiteit Leiden Zweiphasensystem mit kontrollierter Freigabe
US6569152B2 (en) 2000-03-21 2003-05-27 Farrington Pharmaceuticals, Llc Sustained release delivery systems for solutes
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
EE05358B1 (et) * 2000-12-14 2010-12-15 Ortho-Mcneil Pharmaceutical, Inc. Steroidhormoonprodukt ja selle valmistamismeetod
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
ATE502621T1 (de) 2001-11-14 2011-04-15 Durect Corp Katheterinjizierbare depotzusammensetzungen und deren verwendung
IL162000A0 (en) * 2001-11-14 2005-11-20 Alza Corp Injectable depot compositions and use thereof
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
PL213565B1 (pl) * 2002-07-29 2013-03-29 Glaxo Group Ltd Preparat o przedluzonym uwalnianiu zawierajacy lamotrygine
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
NZ537955A (en) * 2002-07-31 2007-10-26 Alza Corp Injectable depot compositions and uses thereof
DK1539101T3 (da) * 2002-07-31 2009-04-27 Alza Corp Injicerbare, multi-modale polymere depotsammens tninger og anvendelser deraf
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
US20050163847A1 (en) * 2004-01-21 2005-07-28 Andrx Pharmaceuticals, Llc Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
GB0403628D0 (en) * 2004-02-18 2004-03-24 Arrow Group Ltd Compression-coated tablets and the manufacture thereof
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
ATE489079T1 (de) * 2005-12-29 2010-12-15 Osmotica Kereskedelmi Es Szolgaltata Kft Mehrschichtige tablette mit dreifacher freisetzungskombination
US8691272B2 (en) * 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
DE102007026037A1 (de) 2007-06-04 2008-12-11 Lts Lohmann Therapie-Systeme Ag Gastroretentives System mit Alginat-Körper
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
WO2010017821A1 (en) * 2008-08-14 2010-02-18 Daniel Bar-Shalom Coated tablets with a remaining degradation surface over the time8
WO2010096820A1 (en) * 2009-02-23 2010-08-26 Eurand, Inc. Controlled release compositions comprising anti-cholinergic drugs
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
SG10201504529WA (en) * 2010-03-09 2015-07-30 Alkermes Pharma Ireland Ltd Alcohol Resistant Enteric Pharmaceutical Compositions
AU2011342893A1 (en) 2010-12-13 2013-05-02 Purdue Pharma L.P. Controlled release dosage forms
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
US9988669B2 (en) 2014-04-14 2018-06-05 Abbott Molecular Inc. Medium used for blood sample collection and transport
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US480076A (en) * 1892-08-02 Thomas p
US3113076A (en) * 1956-07-03 1963-12-03 Henry R Jacobs Medicinal tablets
GB1022171A (en) * 1961-06-15 1966-03-09 Wellcome Found Prolonged release oral pharmaceutical tablets and their manufacture
US3851648A (en) * 1973-10-11 1974-12-03 Mead Johnson & Co Zero-order release device
US4816262A (en) * 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance

Also Published As

Publication number Publication date
DE69207863T2 (de) 1996-06-05
NO924372L (no) 1993-05-14
DK0542364T3 (da) 1996-03-11
EP0542364B1 (de) 1996-01-24
JP4166716B2 (ja) 2008-10-15
IL103723A0 (en) 1993-04-04
CZ337392A3 (en) 1993-10-13
DE69207863D1 (de) 1996-03-07
AU2827292A (en) 1993-05-20
US5342627A (en) 1994-08-30
TW262387B (de) 1995-11-11
JP2004189754A (ja) 2004-07-08
AU658942B2 (en) 1995-05-04
JPH05262640A (ja) 1993-10-12
NZ245100A (en) 1995-06-27
ES2083074T3 (es) 1996-04-01
EP0542364A1 (de) 1993-05-19
CA2082740C (en) 2003-10-14
NO924372D0 (no) 1992-11-12
GR3019431T3 (en) 1996-06-30
CA2082740A1 (en) 1993-05-14
JP3768247B2 (ja) 2006-04-19

Similar Documents

Publication Publication Date Title
ATE133331T1 (de) Vorrichtung zur kontrollierten wirkstoffreigabe
DE69033861D1 (de) Herstellung eines Dosierungsmittels
ES2060074T3 (es) Una preparacion farmaceutica de liberacion controlada y un metodo para su obtencion.
DE68905850T2 (de) Zusammensetzung zur Beschichtung der Aussenoberfläche von Sportbällen und so erhaltene Bälle.
DE58901990D1 (de) Feste pharmazeutische retardform.
ATE439770T1 (de) Riechstoffzusammensetzung
DK618088A (da) Farmaceutisk doseringsform til kontrolleret afgivelse af aktivt stof
PT93168A (pt) Processo para a preparacao de dispositivos distribuidores nomeadamente de capsulas contendo ingredientes activos
DE3486409D1 (de) Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
DK0615442T3 (da) Solreguleret termokolloidmatrix på gelatinebasis til perorale former med retarderet frigivelse.
MY106930A (en) Controlled release device
DE3587929D1 (de) Gerätekombination zur Bodenlockerung und Krümelung einer obersten Bodenschicht.
FR2748209B1 (fr) Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs
DK179090A (da) Anordning til intraruminal indgivelse af medikamenter
JPS5416444A (en) Optically active alpha-cyano-3-phenoxybenzyl 2-(4-chlorophenyl)-isovalerate and its preparation
RU92004402A (ru) Устройство для регулируемого выделения активного вещества и способ его изготовления
TH16921A (th) อุปกรณ์การปลดปล่อยชนิดควบคุม
JPS53130033A (en) Electron beam sensitive material
JPS55119007A (en) Method of projecting or imaging directional pattern
EP0305194A3 (de) Tierärztliche Zusammensetzung
JPS57163302A (en) Water-soluble insecticidal and germicidal gel composition
JPS644020A (en) X-ray mask

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee